Arginine deprivation as a targeted therapy for cancer.

Current pharmaceutical design2008Feun L, You M, Wu CJ, et al.

Scholarly article — Journal Article / Research Support, N.I.H., Extramural / Research Support, U.S. Gov't, Non-P.H.S. / Review / research-article

Study designReview

SubjectHuman & animal

Record checks

Study design: Review
Subject: Human & animal
Publication year: 2008
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 13 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

The abstract is not reproduced here. Please consult the original source.

MeSH

AnimalsAntineoplastic AgentsArginineArgininosuccinate SynthaseCarcinoma, HepatocellularClinical Trials as TopicDrug Delivery SystemsGene Expression Regulation, NeoplasticHumansHydrolasesLiver NeoplasmsMelanomaPolyethylene GlycolsSkin Neoplasms

DOI 10.2174/138161208784246199

PMID 18473854

View source →